Anthony Morlandt

Anthony Morlandt, MD, DDS is a Professor at the University of Alabama at Birmingham (UAB), holding dual appointments in the School of Dentistry (Oral & Maxillofacial Surgery) and School of Medicine (Otolaryngology). He serves as Chief of Oral Oncology at UAB Medicine and directs the Head and Neck Oncology Fellowship program. His clinical focus includes oral oncology and head and neck microvascular surgery, with research spanning cancer chemoprevention, fluorescence-guided surgical margins, and 3D-planned reconstructive techniques.

• Education:
  • MD/Residency from UAB
  • DDS (magna cum laude) from University of Texas Health Sciences Center
  • Postdoctoral Fellowship at University of Florida

Research Interests center on:

• Optical imaging for tumor margin detection using cetuximab-IRDye800
• Microvascular free flap outcomes optimization
• Management of medication-related osteonecrosis of the jaw (MRONJ)
• AI-driven risk assessment for oral premalignant lesions

Scientific Contributions include 15+ peer-reviewed articles on fluorescence technology in surgery, reconstructive methods, and oral cancer biology. His work establishes standardized ratiometric thresholds for fluorescence imaging and minimally invasive titanium cutting guides, with significant citations in Clinical Cancer Research and Head and Neck.

Awards & Recognition:

• AAOMS Faculty Educator Development Award (2015)
• OMS Foundation Milam Award (2016)
• Multiple NIH/NIH-affiliated research grants
• Leadership in American Head and Neck Society